OTC Markets OTCQB - Delayed Quote USD
NUREXONE BIOLOGIC INC (NRXBF)
0.4920
+0.0063
+(1.30%)
At close: April 23 at 2:59:05 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
5,009
5,009
3,657
5,541
1,713
Operating Income
-5,009
-5,009
-3,657
-5,541
-1,713
Net Non Operating Interest Income Expense
31
31
42
-18
-13
Other Income Expense
-65
-65
-24
-2,610
79
Pretax Income
-5,043
-5,043
-3,639
-8,169
-1,647
Net Income Common Stockholders
-5,043
-5,043
-3,639
-8,169
-1,647
Diluted NI Available to Com Stockholders
-5,043
-5,043
-3,639
-8,169
-1,647
Basic EPS
-0.08
-0.08
-0.08
-0.22
-0.04
Diluted EPS
-0.08
-0.08
-0.08
-0.22
-0.04
Basic Average Shares
65,417.2890
65,417.2890
44,722.2880
37,733.7030
42,383.9630
Diluted Average Shares
65,417.2890
65,417.2890
44,722.2880
37,733.7030
42,383.9630
Total Operating Income as Reported
-5,009
-5,009
-3,657
-7,619
-1,713
Total Expenses
5,009
5,009
3,657
5,541
1,713
Net Income from Continuing & Discontinued Operation
-5,043
-5,043
-3,639
-8,169
-1,647
Normalized Income
-5,020
-5,020
-3,637
-5,625
-1,726
Interest Expense
16
16
3
33
12
Net Interest Income
31
31
42
-18
-13
EBIT
-5,027
-5,027
-3,636
-8,136
-1,635
EBITDA
-4,942
-4,942
-3,603
-8,122
-1,635
Reconciled Depreciation
85
85
33
6
--
Net Income from Continuing Operation Net Minority Interest
-5,043
-5,043
-3,639
-8,169
-1,647
Total Unusual Items Excluding Goodwill
-23
-23
-2
-2,544
79
Total Unusual Items
-23
-23
-2
-2,544
79
Normalized EBITDA
-4,919
-4,919
-3,601
-5,578
-1,714
12/31/2021 - 11/10/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LSB LakeShore Biopharma Co., Ltd
1.3300
0.00%
IMRN Immuron Limited
1.7205
-2.80%
BCT.TO BriaCell Therapeutics Corp.
8.45
+18.68%
DRTS Alpha Tau Medical Ltd.
2.6400
-0.38%
CLGN CollPlant Biotechnologies Ltd.
2.2100
+7.28%
PASG Passage Bio, Inc.
0.3250
-3.27%
PPBT Purple Biotech Ltd
2.7300
+1.11%
MRKR Marker Therapeutics, Inc.
1.2700
+6.72%
SCPH scPharmaceuticals Inc.
2.5000
-3.85%
SVA.TO Sernova Biotherapeutics Inc
0.2050
-6.82%